Clinical Trial

Clinical Prognostic Score to Predict Relapse in VL

Study acronym: CPS

Recruiting

Summary

This prospective cohort study has the aim to develop a prognostic tool to predict relapse in patients suffering from visceral leishmaniasis (VL) from VL endemic regions in Ethiopia. Therefore, comprehensive clinical and laboratory characterization of all confirmed VL patients before and during treatment will be performed in order to identify the factors that determine prognosis of the patients. This approach would result in more efficient patient care and would reduce the case fatality and morbidity, and improve follow-up and care for those at risk of VL relapse.

Protocol Amendment History 4 amendments

This ClinicalTrials.gov record has been amended 4 times since 2022-10-27; most recent amendment 2024-03-04.

Status change: Not Yet Recruiting → Recruiting 2023-02-28

Trial Details

NCT Number	NCT05602610
Lead Sponsor	Institute of Tropical Medicine, Belgium Collaborators: University of Gondar
Conditions	Visceral Leishmaniasis
Enrollment	741 participants
Start Date	2023-02-03
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2024-03-05